Suppr超能文献

blaOXA-58 基因及其由 IS1006 和 ISAba3 样元件提供的杂合启动子对基因组种 13TU 中的耐β-内酰胺的贡献。

Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU.

机构信息

Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, and Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei, 11217, Taiwan.

出版信息

Antimicrob Agents Chemother. 2010 Aug;54(8):3107-12. doi: 10.1128/AAC.00128-10. Epub 2010 Jun 1.

Abstract

The contribution of the blaOXA-58 gene and its promoter to beta-lactam resistance has not been validated in Acinetobacter spp. other than Acinetobacter baumannii. We identified a multidrug-resistant (including carbapenem resistance) Acinetobacter genomic species 13TU in which blaOXA-58 was the only detected carbapenemase gene. The blaOXA-58 gene was plasmid located, flanked by ISAba3 (downstream) and an ISAba3-like element (upstream). An IS1006 element was inserted into ISAba3-like (IS1006-DeltaISAba3-like) to generate a hybrid promoter for blaOXA-58, with a -35 promoter located in IS1006 and a -10 promoter in ISAba3-like. The reference strain of Acinetobacter genomic species 13TU, ATCC 17903, revealed higher MICs of amoxicillin, ticarcillin, and piperacillin and heteroresistance to imipenem and meropenem when it was transformed with a shuttle vector containing a fragment encompassing DeltaISAba3-like-blaOXA-58, compared to the same host containing only blaOXA-58. When the fragment was changed from DeltaISAba3-like-blaOXA-58 to IS1006-DeltaISAba3-like-blaOXA-58, the ATCC 17903 transformant revealed a markedly higher level of blaOXA-58 transcription (12-fold), increased cefuroxime and piperacillin-tazobactam MICs, and homoresistance to imipenem and meropenem. Different roles of the insertion elements preceding the blaOXA-58 gene in Acinetobacter genomic species 13TU are demonstrated. The ISAba3-like--blaOXA-58 construct can mediate resistance to penicillin derivatives but only heteroresistance to carbapenems. The insertion of IS1006 into ISAba3-like, generating a hybrid promoter, could further enhance the transcription of blaOXA-58 and mediate homoresistance to carbapenems and also enhanced resistance to piperacillin-tazobactam.

摘要

blaOXA-58 基因及其启动子对除鲍曼不动杆菌以外的其他不动杆菌属细菌产生的β-内酰胺类耐药性的作用尚未得到证实。我们在一株多药耐药(包括碳青霉烯类耐药)的基因组种 13TU 型不动杆菌中鉴定出 blaOXA-58 为唯一检出的碳青霉烯酶基因。blaOXA-58 基因位于质粒上,下游为 ISAba3,上游为 ISAba3 样元件。IS1006 元件插入 ISAba3 样元件(IS1006-DeltaISAba3-like)中,为 blaOXA-58 生成一个杂合启动子,-35 启动子位于 IS1006 中,-10 启动子位于 ISAba3 样元件中。参考菌株基因组种 13TU 型不动杆菌 ATCC 17903 与仅含有 blaOXA-58 的相同宿主相比,当含有包含 DeltaISAba3-like-blaOXA-58 片段的穿梭载体转化时,其阿莫西林、替卡西林和哌拉西林 MIC 值更高,对亚胺培南和美罗培南的异质性耐药性更强。当片段由 DeltaISAba3-like-blaOXA-58 变为 IS1006-DeltaISAba3-like-blaOXA-58 时,ATCC 17903 转化株的 blaOXA-58 转录水平显著升高(12 倍),头孢呋辛和美罗培南/哌拉西林他唑巴坦 MIC 值升高,对亚胺培南和美罗培南的同源耐药性增强。该研究展示了 blaOXA-58 基因前插入元件在基因组种 13TU 型不动杆菌中的不同作用。ISAba3 样- blaOXA-58 构建体可介导对青霉素衍生物的耐药性,但仅对碳青霉烯类产生异质性耐药性。IS1006 插入 ISAba3 样元件,生成杂合启动子,可进一步增强 blaOXA-58 的转录,并介导对碳青霉烯类的同源耐药性,同时增强对哌拉西林-他唑巴坦的耐药性。

相似文献

3
Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.
Infect Genet Evol. 2015 Apr;31:305-11. doi: 10.1016/j.meegid.2015.02.017. Epub 2015 Feb 24.
5
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
Int J Antimicrob Agents. 2010 May;35(5):439-43. doi: 10.1016/j.ijantimicag.2009.11.020. Epub 2010 Jan 27.
7
Genetic characterization of plasmid-borne bla and bla in Acinetobacter pittii in Shaanxi, China.
J Glob Antimicrob Resist. 2024 Sep;38:167-172. doi: 10.1016/j.jgar.2024.05.007. Epub 2024 May 19.
8
Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
PLoS One. 2015 Sep 4;10(9):e0137174. doi: 10.1371/journal.pone.0137174. eCollection 2015.
10
Genetic Characterization of Plasmid-Borne in Distinct Acinetobacter Species.
mSphere. 2019 Oct 16;4(5):e00376-19. doi: 10.1128/mSphere.00376-19.

引用本文的文献

4
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022.
6
Genomic characterization of triple-carbapenemase-producing .
JAC Antimicrob Resist. 2021 Dec 18;3(4):dlab191. doi: 10.1093/jacamr/dlab191. eCollection 2021 Dec.
7
Prevalence and Characterization of Carbapenem-Hydrolyzing Class D β-Lactamase-Producing Isolates From Ghana.
Front Microbiol. 2020 Nov 13;11:587398. doi: 10.3389/fmicb.2020.587398. eCollection 2020.
8
Profile of Enterobacteria Resistant to Beta-Lactams.
Antibiotics (Basel). 2020 Jul 15;9(7):410. doi: 10.3390/antibiotics9070410.
9
Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia.
J Clin Med. 2020 Jan 19;9(1):275. doi: 10.3390/jcm9010275.

本文引用的文献

1
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
Int J Antimicrob Agents. 2010 May;35(5):439-43. doi: 10.1016/j.ijantimicag.2009.11.020. Epub 2010 Jan 27.
2
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2009 Dec;53(12):5035-8. doi: 10.1128/AAC.00856-09. Epub 2009 Sep 21.
4
Diversity, epidemiology, and genetics of class D beta-lactamases.
Antimicrob Agents Chemother. 2010 Jan;54(1):24-38. doi: 10.1128/AAC.01512-08. Epub 2009 Aug 31.
5
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother. 2009 Aug;53(8):3528-33. doi: 10.1128/AAC.00178-09. Epub 2009 Jun 1.
6
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Antimicrob Agents Chemother. 2009 Jul;53(7):3010-6. doi: 10.1128/AAC.01164-08. Epub 2009 Apr 20.
8
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Antimicrob Agents Chemother. 2008 Nov;52(11):4115-20. doi: 10.1128/AAC.00366-08. Epub 2008 Aug 25.
9
Acinetobacter baumannii: emergence of a successful pathogen.
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
10
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08. Epub 2008 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验